> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-213/
- Published: 2019-03-03T12:00:00.000Z
- Updated: 2026-09-15T01:09:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143519

[**Comments Sought on Cannabis Scheduling Recommendations**](https://www.fdaweb.com/comments-sought-on-cannabis-scheduling-recommendations/)  
*Federal Register* notice: FDA seeks comments on World Health Organization recommendations to impose international manufacturing and distributing restrictions on certain cannabis drug substances. 03/01/2019

[**Comments Sought on Fentanyl Scheduling Recommendations**](https://www.fdaweb.com/comments-sought-on-fentanyl-scheduling-recommendations/)  
*Federal Register* notice: FDA is seeking comments on World Health Organization drug scheduling recommendations on fentanyl-related narcotic drugs. 03/01/2019

[**Meeting on Rare Disease Patient Perspectives**](https://www.fdaweb.com/meeting-on-rare-disease-patient-perspectives/)  
*Federal Register* notice: FDA announces a public meeting and an opportunity for public comment on “Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities.” 02/28/2019

[**New Address for Generic Drugs Document Room**](https://www.fdaweb.com/new-address-for-generic-drugs-document-room/)  
*Federal Register* notice: FDA amends its regulations to reflect a change of address for CDER’s Office of Generic Drugs Document Room from Rockville, MD, to Beltsville, MD. 02/28/2019

[**Info Collection Extension for Formal Dispute Resolution**](https://www.fdaweb.com/info-collection-extension-for-formal-dispute-resolution/)  
*Federal Register* notice: FDA submits to OMB an information collection extension entitled “Formal Dispute Resolution; Appeals Above the Division Level.” 02/27/2019

[**Draft Guide on Drug Continuous Manufacturing**](https://www.fdaweb.com/draft-guide-on-drug-continuous-manufacturing/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Quality Considerations for Continuous Manufacturing.” 02/27/2019

[**National Center for Toxicological Research Advisory Committee**](https://www.fdaweb.com/national-center-for-toxicological-research-advisory-committee/)  
*Federal Register* notice: FDA announces a 3/19-20 meeting of the National Center for Toxicological Research’s Science Advisory Board. 02/27/2019

[**Proposed Rule on OTC Sunscreen Monograph**](https://www.fdaweb.com/proposed-rule-on-otc-sunscreen-monograph/)  
*Federal Register* notice: FDA issues a proposed rule to put into effect a final monograph for nonprescription, over-the-counter sunscreen drug products. 02/26/2019

[**Draft Guide on Drug Food-effect Studies**](https://www.fdaweb.com/draft-guide-on-drug-food-effect-studies/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Assessing the Effects of Food on Drugs in INDs and NDAs — Clinical Pharmacology Considerations.” 02/26/2019